METTL3 and neoplasm: Compared to patients with early-stage CC, Mettl3 expression levels were significantly higher in patients with advanced CC, suggesting a gradual increase in Mettl3 during the process of tumor malignancy (Hu et al., 2020; Shen et al., 2022a).